IDEXX Laboratories, Inc. (IDXX)
NASDAQ · Health Care · market cap 44.45B
Share price
$671.64
At the last nightly close
Intrinsic value
$379.46
Range $231.38 – $267.86 before any credit for growth. The figure above is $231.38 × 1.64, the credit the franchise record earns.
Margin of safety
-43.5%
($379.46 − $671.64) ÷ $671.64
EV / EBIT
112.4
On the median operating profit of 15 fiscal years through 2025.
How these numbers are computed
The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above starts from the lower of the first two; the Graham Number never enters it.
The frame gives no credit for growth unless the company has earned it: only a return on invested capital that has beaten the cost of capital year after year earns a growth credit, and that credit is capped. A company that compounds will therefore usually read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.
The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.
Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-09-03.
Key metrics
Market position
Annual financials
| Period | Revenue | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|
| 2025-FY | 4.30B | 1.36B | 1.06B | 13.17 | 1.04B |
| 2024-FY | 3.90B | 1.13B | 887.9M | 10.77 | 798.1M |
| 2023-FY | 3.66B | 1.10B | 845.0M | 10.17 | 772.9M |
| 2022-FY | 3.37B | 898.8M | 679.1M | 8.12 | 384.1M |
| 2021-FY | 3.22B | 932.0M | 744.8M | 8.60 | 636.0M |
Filed figures from SEC EDGAR, in the reporting currency.
Recent news
- IDEXX Laboratories (IDXX) Earnings: Latest Report, Earnings Call & Financialspublic.com
- IDEXX Laboratories (IDXX) Stock Price & Overviewstockanalysis.com
- IDEXX Laboratories, Inc. (IDXX) Latest Stock News & Headlines - Yahoo Financefinance.yahoo.com
- IDEXX Laboratories (IDXX) Stock Analysis 2026 –Pet Healthcare Compounder or Too Expensive?youtube.com
- IDEXX Laboratories, Inc. (IDXX) Stock Price, Quote, News & Analysis | Seeking Alphaseekingalpha.com
Headlines link to their source. Sperio does not republish article text.
The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on IDXX.
Run the board on IDXX10 free analyses · no signup, no card
This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.